What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size

[1]  P. Mateu-Gelabert,et al.  “It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives , 2021, Harm Reduction Journal.

[2]  B. Saloner,et al.  Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis. , 2021, Journal of substance abuse treatment.

[3]  M. Kariisa,et al.  Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019 , 2021, MMWR. Morbidity and mortality weekly report.

[4]  Yong-Yeol Ahn,et al.  Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018 , 2021, JAMA network open.

[5]  Ryan W. Carpenter,et al.  Commentary on Furr-Holden et al. 2020: As opioid overdose deaths accelerate among Black Americans, COVID-19 widens inequities-a critical need to invest in community-based approaches. , 2021, Addiction.

[6]  H. Hedegaard,et al.  Drug Overdose Deaths in the United States, 1999-2019. , 2020, NCHS data brief.

[7]  Kara E. Rudolph,et al.  A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic , 2020, Annual review of public health.

[8]  A. Weinberger,et al.  Opioid use disorder trends from 2002 to 2017 by cigarette smoking status in the United States. , 2020, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[9]  R. Sadler,et al.  African Americans now Outpace Whites in Opioid-Involved Overdose Deaths: A Comparison of Temporal Trends from 1999-2018. , 2020, Addiction.

[10]  M. Greenwald,et al.  US national treatment admissions with opioids and benzodiazepines. , 2020, Drug and alcohol review.

[11]  Ross J. Harris,et al.  Estimating the prevalence of problem drug use from drug-related mortality data , 2020, Addiction.

[12]  David K. Wyant,et al.  Compositional and contextual factors associated with drug overdose deaths in the United States , 2020, Journal of addictive diseases.

[13]  N. Volkow,et al.  Reported Heroin Use, Use Disorder, and Injection Among Adults in the United States, 2002-2018. , 2020, JAMA.

[14]  P. Matson,et al.  Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults. , 2020, JAMA pediatrics.

[15]  T. Land,et al.  Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose. , 2020, Annals of emergency medicine.

[16]  L. Degenhardt,et al.  All-Cause and Cause-Specific Mortality Among People Using Extramedical Opioids: A Systematic Review and Meta-analysis. , 2019, JAMA psychiatry.

[17]  Jürgen Landes,et al.  E-Synthesis: A Bayesian Framework for Causal Assessment in Pharmacosurveillance , 2019, Front. Pharmacol..

[18]  T. Land,et al.  Touchpoints - Opportunities to predict and prevent opioid overdose: A cohort study. , 2019, Drug and alcohol dependence.

[19]  Jessie K. Edwards,et al.  Estimating Hidden Population Sizes with Venue-based Sampling , 2019, Epidemiology.

[20]  A. Bohnert,et al.  Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder , 2019, JAMA network open.

[21]  Nila A. Sathe,et al.  Estimating the Prevalence of Opioid use Disorder in the Cincinnati Region using Probabilistic Multiplier Methods and Model Averaging , 2019, Journal of health economics and outcomes research.

[22]  Laura F White,et al.  Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis , 2018, American journal of public health.

[23]  Hawre Jalal,et al.  Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016 , 2018, Science.

[24]  J. Rehm,et al.  Crude estimates of prescription opioid-related misuse and use disorder populations towards informing intervention system need in Canada. , 2018, Drug and alcohol dependence.

[25]  C. Florence,et al.  US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015. , 2018, Journal of substance abuse treatment.

[26]  W. Tu,et al.  Community Engagement and Venue-Based Sampling in Adolescent Male Sexually Transmitted Infection Prevention Research. , 2018, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[27]  Benjamin P Linas,et al.  Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. , 2018, Journal of substance abuse treatment.

[28]  T. Zheng,et al.  A Bayesian evidence synthesis approach to estimate disease prevalence in hard-to-reach populations: hepatitis C in New York City. , 2018, Epidemics.

[29]  D. Houry,et al.  Underlying Factors in Drug Overdose Deaths. , 2017, JAMA.

[30]  J. Hargreaves,et al.  Sample Size Calculations for Population Size Estimation Studies Using Multiplier Methods With Respondent-Driven Sampling Surveys , 2017, JMIR public health and surveillance.

[31]  Christopher M. Jones,et al.  Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health , 2017, Annals of Internal Medicine.

[32]  K. Feder,et al.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. , 2017, Drug and alcohol dependence.

[33]  Fang Zhang,et al.  Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014 , 2017, JAMA pediatrics.

[34]  B. Grant,et al.  Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions , 2017, JAMA psychiatry.

[35]  S. Martins,et al.  Prescription opioid use disorder and heroin use among 12-34 year-olds in the United States from 2002 to 2014. , 2017, Addictive behaviors.

[36]  Mark A. Schuster,et al.  Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2000-2014 , 2017 .

[37]  T. Vos,et al.  Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.

[38]  Katherine R. McLaughlin,et al.  Measuring a hidden population: A novel technique to estimate the population size of women with sexual violence-related pregnancies in South Kivu Province, Democratic Republic of Congo , 2016, Journal of epidemiology and global health.

[39]  Mark S Handcock,et al.  Estimating the Size of Hidden Populations Using Respondent-driven Sampling Data: Case Examples from Morocco , 2015, Epidemiology.

[40]  Forrest W. Crawford,et al.  Hidden Population Size Estimation From Respondent-Driven Sampling: A Network Approach , 2015, Journal of the American Statistical Association.

[41]  R. Dart,et al.  Trends in opioid analgesic abuse and mortality in the United States. , 2015, The New England journal of medicine.

[42]  R. Rosenblatt,et al.  Geographic and Specialty Distribution of US Physicians Trained to Treat Opioid Use Disorder , 2015, The Annals of Family Medicine.

[43]  Matthew J. Salganik,et al.  Generalizing the Network Scale-up Method , 2014, Sociological methodology.

[44]  R. Merrill,et al.  Unintentional Prescription Opioid-Related Overdose Deaths: Description of Decedents by Next of Kin or Best Contact, Utah, 2008–2009 , 2013, Journal of General Internal Medicine.

[45]  Mark S Handcock,et al.  Estimating hidden population size using Respondent-Driven Sampling data. , 2012, Electronic journal of statistics.

[46]  Jennifer McNeely,et al.  Estimating the prevalence of illicit opioid use in New York City using multiple data sources , 2012, BMC Public Health.

[47]  S. Friedman,et al.  Estimates of the Population Prevalence of Injection Drug Users among Hispanic Residents of Large US Metropolitan Areas , 2012, Journal of Urban Health.

[48]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[49]  Ruiguang Song,et al.  Estimated HIV Incidence in the United States, 2006–2009 , 2011, PloS one.

[50]  S. Friedman,et al.  Estimating the Prevalence of Injection Drug Users in the U.S. and in Large U.S. Metropolitan Areas from 1992 to 2002 , 2008, Journal of Urban Health.

[51]  S. Friedman,et al.  Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution , 2006, Sexually Transmitted Infections.

[52]  Alex J. Sutton,et al.  Multiparameter evidence synthesis in epidemiology and medical decision‐making: current approaches , 2006 .

[53]  Matthew Hickman,et al.  Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths. , 2004, American journal of epidemiology.

[54]  M. Frischer,et al.  Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. , 2003, Addiction.

[55]  A E Ades,et al.  Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[56]  Lillian S. Lin,et al.  A Venue-Based Method for Sampling Hard-to-Reach Populations , 2001, Public health reports.

[57]  M. Farrell,et al.  Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. , 1999, Addiction.

[58]  Gretchen McHenry,et al.  2015 NATIONAL SURVEY ON DRUG USE AND HEALTH , 2015 .

[59]  Christopher M. Jones,et al.  CDC Grand Rounds: Prescription Drug Overdoes - A U.S. Epidemic , 2012 .

[60]  Jill Manit,et al.  National Survey on Drug Use and Health , 2009 .

[61]  S. Friedman,et al.  Estimating the Prevalence of Injection Drug Use among Black and White Adults in Large U.S. Metropolitan Areas over Time (1992–2002): Estimation Methods and Prevalence Trends , 2008, Journal of urban health : bulletin of the New York Academy of Medicine.

[62]  L. Degenhardt,et al.  Estimating the prevalence of problematic drug use: a review of methods and their application , 2002 .